Clinical Trials on Ovarian Seromucinous Carcinoma in Canada
Total 1773 results
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Undifferentiated Carcinoma | Ovarian... and other conditionsUnited States, Canada, Singapore
-
National Cancer Institute (NCI)AstraZeneca; NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian... and other conditionsUnited States, Canada, Korea, Republic of, Japan
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Endometrial Carcinoma | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Ovarian Sarcoma | Recurrent Ovarian Epithelial Cancer | Stage IV Endometrial Carcinoma | Ovarian Stromal Cancer | Recurrent Ovarian Germ Cell Tumor and other conditionsCanada
-
National Cancer Institute (NCI)NRG Oncology; Canadian Cancer Trials GroupActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian... and other conditionsUnited States, Canada, Puerto Rico, Korea, Republic of, Japan
-
CHU de Quebec-Universite LavalThe Cancer Research SocietyCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian Cancer | Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage IV Borderline Ovarian...Canada
-
University Health Network, TorontoCompletedPlatinum-resistant Epithelial Ovarian CancerCanada
-
University Health Network, TorontoCompletedStage IV Ovarian Cancer | Stage III Ovarian CancerCanada
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Recurrent Uterine Corpus Carcinoma | Stage III Ovarian Cancer AJCC v6 and v7 | Stage III Uterine Corpus Cancer AJCC v7 | Stage IV Ovarian Cancer AJCC v6 and v7 | Stage IV Uterine Corpus Cancer AJCC v7 | Adult Solid NeoplasmCanada
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity CancerCanada
-
University Health Network, TorontoCompleted
-
University of British ColumbiaBritish Columbia Cancer AgencyNot yet recruiting
-
University Health Network, TorontoAstraZenecaCompletedOvarian CancerCanada
-
Ottawa Regional Cancer CentreUnknownOvarian CancerCanada
-
University Health Network, TorontoAstraZenecaCompleted
-
Ottawa Hospital Research InstituteCompleted
-
University of British ColumbiaCompleted
-
University Health Network, TorontoActive, not recruitingOvarian Cancer | Small Cell Carcinoma, Hypercalcaemic TypeCanada
-
University Health Network, TorontoCompletedMicrosatellite Stable Colorectal Carcinoma | Platinum Resistant Epithelial Ovarian Cancer Type II | Estrogen Receptor Positive and HER2 Negative Breast CancerCanada
-
Sunnybrook Health Sciences CentreGlaxoSmithKlineRecruitingOvarian Cancer | Stage IV Ovarian Cancer | High Grade Ovarian Serous Adenocarcinoma | Stage III Ovarian CancerCanada
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaTerminatedEpithelial Ovarian CancerCanada
-
British Columbia Cancer AgencyUniversity of Victoria; University of Texas Southwestern Medical Center; Van...RecruitingOvarian Cancer | AscitesCanada
-
British Columbia Cancer AgencyCarraressi Foundation OVCARETerminatedOvarian Neoplasms | Ovarian CancerCanada
-
Azaya Therapeutics, Inc.UnknownCancer | Ovarian Cancer | Ovarian Epithelial Cancer Recurrent | Malignant Female Reproductive System Neoplasm | Ovarian TumorCanada, United States
-
EndocyteCompletedOvary CancerCanada, United States
-
British Columbia Cancer AgencyRecruitingOvarian Cancer | Platinum-resistant Ovarian CancerCanada
-
University Health Network, TorontoTerminated
-
Andrea McCartOntario Institute for Cancer ResearchWithdrawn
-
University of British ColumbiaGenzyme, a Sanofi CompanyTerminatedEpithelial Ovarian CancerCanada, United States
-
National Cancer Institute (NCI)CompletedUterine Carcinosarcoma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Endometrial Serous Adenocarcinoma | Lung Carcinoid Tumor | Metastatic... and other conditionsUnited States, Canada
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR)Recruiting
-
University Health Network, TorontoCompletedOvarian Cancer | Steroid Cell Tumor, MalignantCanada
-
University of MichiganNational Cancer Institute (NCI)CompletedOvarian Cancer Risk | Risk-reducing Surgery | Fallopian Tube Fimbriae | Ovarian Cortical Inclusion CystsUnited States, Canada
-
University of SaskatchewanNot yet recruitingAnaemia in Ovarian CarcinomaCanada
-
Centre de recherche du Centre hospitalier universitaire...Université de SherbrookeCompleted
-
Janssen Research & Development, LLCCompletedNeoplasmsUnited States, Spain, Canada, Belgium
-
Grupo Español de Investigación en Cáncer de OvarioAstraZenecaCompletedAdvanced Ovarian CancerSpain
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerCanada
-
Opna-IO LLCTerminatedEpithelial Ovarian Cancer | Gynecologic NeoplasmsUnited States, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Stage IV Fallopian Tube Cancer | Stage IV Ovarian Cancer | Stage IV Primary Peritoneal CancerUnited States, Canada
-
Ontario Clinical Oncology Group (OCOG)PfizerCompleted
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Ovarian Carcinoma | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Skin Melanoma | Recurrent Non-Small Cell... and other conditionsCanada
-
CASI Pharmaceuticals, Inc.CompletedOvarian Cancer | Endometrial CancerCanada
-
CASI Pharmaceuticals, Inc.CompletedOvarian Cancer | Peritoneal Cancer | Fallopian CancerUnited States, Canada
-
Sunnybrook Health Sciences CentreCentre hospitalier de l'Université de Montréal (CHUM); Exactis Innovation; Princess...RecruitingOvarian Cancer | Triple Negative Breast Cancer | High Grade Serous CarcinomaCanada
-
McGill UniversityMcGill University Health Centre/Research Institute of the McGill University... and other collaboratorsRecruiting
-
University Health Network, TorontoTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Bowel ObstructionCanada
-
University Health Network, TorontoCompleted
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube Cancer | Stage IIIA Fallopian Tube Cancer | Stage IIIB Fallopian Tube Cancer | Stage IIIC Fallopian Tube Cancer and other conditionsCanada
-
University Health Network, TorontoGlaxoSmithKlineRecruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Serous Cancer | High Grade Endometrioid CancerCanada